Merck recalls Emend and Noxafil oral suspension medicines over possible metal particles
Some Emend (aprepitant) and Noxafil Powdermix (posaconazole) oral suspension products may contain tiny metal particles, which is why they were recalled.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03; Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC…
- Company
- Merck Sharp & Dohme LLC
- Hazard
- Presence of particulate matter: potential presence of metal particulates in the product.
- Units
- 3 - single dose kits; 845 kits
- Where sold
- Nationwide in the USA
- FDA classification
- Class II · Ongoing
- Classified by FDA
- December 23, 2025
- Recall started
- December 12, 2025
- FDA enforcement report
- December 31, 2025
- Identifiers
- Codes: Lot #: Z014503, Exp 11/15/2027
- FDA recall number: D-0241-2026
- Codes: Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
- FDA recall number: D-0242-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03 | Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
- Reason for recall
- Presence of particulate matter: potential presence of metal particulates in the product.
- Classification
- Class II (Ongoing)
- Distribution
- Nationwide in the USA
- Quantity
- 3 - single dose kits; 845 kits
Related recalls
Guardian Drug recalls Tums, HyVee and CAREone calcium antacid chewables over small metal particles
The chewable calcium carbonate antacid tablets were found to contain small metallic particles, which are foreign material that should not be in the product.
Fresenius Kabi recalls Tyenne (tocilizumab-aazg) 400 mg/20 mL injection vials over glass particles
An internal investigation at the company found glass particles in vials of this injection, so the product contains particulate matter.
Fresenius Kabi USA, LLC · 4,643 20mL-vials